A number of studies have shown the amazing weight loss potential of a new group of drugs, known to many by their brand names as Ozempic (which is for diabetes), Wegovy and Mounjaro. But how do these new drugs work? How were they discovered and who can use them? This is part of a new mini-series called the The Briefing Room Explainers. They’re short versions of previous episodes of the Briefing Room. Presenter: David Aaronovitch Producers: Charlotte McDonald, Kirsteen Knight and Beth Ashmead Latham Studio Manager: Neil Churchill Editor: Richard Vadon Production Co-ordinator: Gemma Ashman

A short history of electric cars in the UK. The UK government wants to ban the sale of petrol cars by 2030. But how is the move to electric vehicles going? This episode is part of a new mini-series called The Briefing Room Explainers. Presenter: David Aaronovitch Producers: Charlotte McDonald, Kirsteen Knight and Beth Ashmead Latham Studio Manager: Neil Churchill Editor: Richard Vadon Production Co-ordinator: Gemma Ashman Guest: Ginny Buckley, Editor-in-Chief and founder of electrifying.com

Dive into the world of tariffs and discover what they really are. Explore how they evolved from mercantilism to modern protectionism. Uncover the surprising truth that American consumers often foot the bill for these taxes. Delve into the tension between free trade and protecting local industries, as well as the impact of global competition. Historical insights reveal the complex economic effects of tariff policies during recent administrations. This discussion sheds light on current trade dynamics and their implications for the future.

Sam Lowe, a Partner at Flint Global consultancy, and Duncan Weldon, an economist and author, delve into the multifaceted world of tariffs. They explore Trump's fascination with tariffs, questioning their implications for U.S. trade and global relations. The discussion highlights historical perspectives on tariffs, the challenges faced by U.S. companies reliant on imports, and the potential fallout of these policies on consumers. Listeners gain insight into the complexities of trade dynamics and the 'weaponized uncertainty' of our modern economic landscape.

In this discussion, Ginny Buckley, an electric vehicle expert and founder of electrifying.com, joins Ian Henry, a professor of Automotive Business Strategy, and David Bailey, an economics professor, to dissect the UK's push towards electric cars. They debate the effectiveness of government policies and the challenges of charging infrastructure. The group also explores foreign competition and the struggles local manufacturers face. It's a candid look at whether Britain can really accelerate its transition from petrol to electric.

In this fascinating discussion, Jennifer Spence, Director at the Belfer Center, Heidi Sevestre, glaciologist, Heather Conley, senior advisor at the German Marshall Fund, and Pavel Devyatkin, senior associate at The Arctic Institute, delve into the dramatic shifts occurring in the Arctic. They cover the alarming effects of climate change on ice loss and global sea levels. The conversation also highlights potential economic opportunities arising from melting ice, strategic geopolitical tensions, and the urgent need for international cooperation in safeguarding this crucial region.

Monica de Bolle, a senior fellow at the Peterson Institute, discusses Argentina's economic challenges, tracing its decline and the factors that led to Javier Milei's rise. Tyler Cowen, a professor at George Mason University, delves into Milei's bold libertarian economic philosophy and its real-world applications. Pablo Castro offers vital on-the-ground insights into how Milei's austerity measures are affecting everyday Argentinians, highlighting both the social disparities and the political complexities in navigating these drastic changes.

New weight loss drugs known commercially as Wegovy and Mounjaro have been demonstrated to have a big effect in helping people to lose weight, and have recently been approved for use in obesity treatment in the NHS in England. In total, 4.1 million people would meet the criteria to be eligible to take one of these drugs. That seems fantastic - an end to obesity in our time. The problem is can we afford these drugs without bankrupting the NHS? How badly do we need them? But will this work? Should we be more ambitious? Can this help the NHS? Or bankrupt it? Guests: John Wilding, Professor of Medicine at The University of Liverpool. Alfie Slade is Government Affairs Lead at the Obesity Health Alliance Naveed Sattar, Professor of Metabolic Medicine at the University of Glasgow. Daniel Susskind, Research Professor in Economics at King's College, London. Dr Ellen Fallows, GP and Vice-President of The British Society of Lifestyle Medicine.Presenter: David Aaronovitch Producers: Charlotte McDonald, Kirsteen Knight and Beth Ashmead Latham Sound engineers: Rod Farquhar, Neva Missirian Editor: Richard Vadon Production Co-ordinator: Gemma Ashman

In under two weeks Syrian rebels have moved through the country and taken Damascus - bringing to an end 50 years of rule by the Assad family. The country borders Israel, Lebanon, Turkey and Iraq, and in which Iran and Russia take the most active of interests. So why did the government of Bashar Al Assad fall so fast, who are HTS the rebels who toppled him, and what does it mean for the region and the world? Charles Lister, Senior Fellow and the Director of the Syria and Countering Terrorism & Extremism programs at the Middle East Institute in Washington DC. Lina Khatib, Director of the SOAS Middle East Institute. Chris Phillips, professor of international relations at queen Mary’s university, an associate at Chatham House and author of The Battle for Syria. Shashank Joshi, defence editor at The Economist.Presenter: David Aaronovitch Producers: Charlotte McDonald, Kirsteen Knight and Beth Ashmead Latham Sound engineers: Rod Farquhar, Neva Missirian Editor: Richard Vadon Production Co-ordinator: Gemma Ashman

North Korean troops are fighting Ukrainians in Russia, while Ukraine has finally been permitted to use US missiles deep into Russian territory. It’s over 1000 days since Vladimir Putin’s full scale invasion of his neighbour and the circle of those involved in the conflict seems to widen. But though the situation changes the central question doesn’t. That question being which side can best stay the bloody course of this war? Ukraine and the West or Russia and its allies? Where do things stand now? Michael Clarke, Visiting Professor in the Department of War Studies, King’s College, London and former Director of the Royal United Services Institute Elina Ribakova, Senior Fellow at Peterson Institute of International Economics in Washington DC Defence Editor of the Economist, Shashank JoshiPresenter: David Aaronovitch Producers: Charlotte McDonald, Kirsteen Knight and Beth Ashmead Latham Sound engineers: Rod Farquhar, Neva Missirian Editor: Richard Vadon Production Co-ordinator: Gemma Ashman